Nu-Med Plus (NUMD) EPS (Basic) Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) EPS (Basic) Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.15% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 62.64% |
| Mar 31, 2025 | 40.85% |
| Dec 31, 2024 | 52.55% |
| Sep 30, 2024 | 41.23% |
| Jun 30, 2024 | 47.78% |
| Mar 31, 2024 | 52.07% |
| Dec 31, 2023 | 37.92% |
| Sep 30, 2023 | 56.70% |
| Jun 30, 2023 | 41.42% |
| Mar 31, 2023 | 37.59% |
| Dec 31, 2022 | 16.62% |
| Sep 30, 2022 | 27.16% |
| Jun 30, 2022 | 25.13% |
| Mar 31, 2022 | 15.72% |
| Dec 31, 2021 | -29.73% |
| Sep 30, 2021 | 39.33% |
| Jun 30, 2021 | 8.33% |
| Mar 31, 2021 | -22.42% |